Transfection Reagents »
ImuThes has developed a number of proprietary reagents for the efficient transfection of siRNA and pDNA
Welcome to the ImuThes website »
Our business is focussed on efficient, systemic and subcellular delivery of biotherapeutics, such as RNAi, plasmid DNA, and proteins to assist turning good ideas into innovative, effective therapies for the treatment of serious chronic disorders and life-threatening diseases.
News »
July 2008
Evaluation Agreement for siRNA Delivery with Second European Big Pharma company.
July 2007
Alliance Agreement with RNAi Co (Tokyo, Japan) for the combination of ImuThes Delivery Technology with RNAi Co Chimera RNAi Technology.
July 2007
Collaboration Agreement with ThiaMedica (Bergen, Norway) for the contribution of ImuThes Technology to new chemical entities in metabolic and cardiovascualar disease.
